ACTIVE

Eurotranspharma Belgium

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result471,1 k €+1 534,9 %over 1 year
Revenue27 M €+1,4 %over 1 year
Equity784,2 k €+150,5 %over 1 year
Workforce131,8 ETP-3,3 %over 1 year

Identity

Source · BCE/KBO

Eurotranspharma Belgium is a Private limited company incorporated in 2013. Its main activity is: Freight transport by road. Its registered office is in Aalst. It employs on average 131,8 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0541.617.712
Incorporation
04/11/2013
Legal form
Private limited company
Registered office
Waterkeringstraat 1
9320 Aalst · FlandreSee on map
Contributed capital
785 550,00 €
Latest accounts
31/12/2025
Average workforce
131,8 ETP
Joint committees (2)
  • 14003
  • 226
Signals
ProfitableGood liquidityPositive cashflowPositive EBITDAHealthy social debtsHigh revenue

Financials

Source · NBB, 12 filings

Trend over 12 financial years

20252024202320222021
Income statement
Revenue27 M €26,7 M €26,3 M €24,1 M €15,5 M €
EBITDA1,1 M €761 k €831,3 k €1,1 M €-127,3 k €
Operating result662,2 k €234,8 k €202 k €315,3 k €-596,7 k €
Net result471,1 k €28,8 k €56,5 k €198,4 k €-623,4 k €
Balance sheet
Equity784,2 k €313,1 k €284,3 k €227,8 k €-620,6 k €
Total assets9,2 M €12,4 M €10,4 M €12,1 M €9,2 M €
Cash1,3 M €1,2 M €758,9 k €1,7 M €675,3 k €
Debts8,4 M €12,1 M €10,2 M €11,9 M €9,8 M €
Other
Workforce131,8 ETP136,3 ETP130,8 ETP118,8 ETP82,0 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 8 ended

Active mandates

BUSINESS PROMOTION & MANAGEMENT

Director · since 02 janvier 2018 · until 30 avril 2026 · 0825.953.911

Represented by Benoît Latteur

Active
Peter Roelands

Mandate

Active

Ended mandates

BUSINESS PROMOTION & MANAGEMENT

Manager · since 02 janvier 2018 · 0825.953.911

Represented by Benoit LATTEUR

Ended
BUSINESS PROMOTION & MANAGEMENT

Director · since 02 janvier 2018 · 0825.953.911

Represented by Benoit LATTEUR

Ended
BUSINESS PROMOTION & MANAGEMENT

Mandate · 0825.953.911

Represented by Benoît Latteur

Ended
Nicolas Richer

Mandate

Ended

Other companies at this address

Waterkeringstraat 1 9320 Aalst
CompanyCBE no.
MOVIANTO BELGIUM● Active
0418.979.622
Transpharma International● Active
0765.495.888

Full financial information

Source · NBB
202520242023202220212020
Type of accountFull modelFull modelFull modelFull modelFull modelFull model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date25/06/202625/06/202511/07/202429/06/202308/11/202225/10/2021
General meeting28/05/202622/05/202514/06/202425/05/202311/10/202227/05/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 12 filings
ModelClosingGeneral meetingFiledLanguageDocument
Full model31/12/202528/05/202625/06/2026DutchPDF
Full model31/12/202422/05/202525/06/2025DutchPDF
Full model31/12/202314/06/202411/07/2024DutchPDF
Full model31/12/202225/05/202329/06/2023DutchPDF
Full model31/12/202111/10/202208/11/2022DutchPDF
Full model31/12/202027/05/202125/10/2021FrenchPDF
Abridged model31/12/201928/05/202030/11/2020FrenchPDF
Abridged model31/12/201830/05/201930/08/2019FrenchPDF
Abridged model31/12/201731/05/201831/08/2018FrenchPDF
Abridged model31/12/201625/05/201722/08/2017FrenchPDF
Full model31/12/201526/05/201626/05/2016FrenchPDF
Full model31/12/201428/05/201512/06/2015FrenchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 8 ended

Active mandates

BUSINESS PROMOTION & MANAGEMENT

Director · since 02 janvier 2018 · until 30 avril 2026 · 0825.953.911

Represented by Benoît Latteur

Active
Peter Roelands

Mandate

Active

Ended mandates

BUSINESS PROMOTION & MANAGEMENT

Manager · since 02 janvier 2018 · 0825.953.911

Represented by Benoit LATTEUR

Ended
BUSINESS PROMOTION & MANAGEMENT

Director · since 02 janvier 2018 · 0825.953.911

Represented by Benoit LATTEUR

Ended
BUSINESS PROMOTION & MANAGEMENT

Mandate · 0825.953.911

Represented by Benoît Latteur

Ended
Nicolas Richer

Mandate

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Other23/09/2026
    —
    PDF
  • Mandates15/06/2026
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Capital / shares31/07/2025
    KAPITAAL - AANDELEN
    PDF
  • Other22/05/2025
    DOEL
    PDF
  • Mandates02/04/2024
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Other09/01/2023
    DIVERSEN
    PDF
  • Mandates12/11/2021
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates13/07/2021
    SIEGE SOCIAL - CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - MODIFICATION FORME JURIDIQUE
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025471,1 k €↑
  2. 2024
    Annual accounts 202428,8 k €↓
  3. 2023
    Annual accounts 202356,5 k €↓
  4. 2022
    Annual accounts 2022198,4 k €↑
  5. 2021
    Annual accounts 2021-623,4 k €↓
  6. 2020
    Annual accounts 2020-102,3 k €↓
  7. 2019
    Annual accounts 2019120,4 k €↑
  8. 2018
    Annual accounts 201819,9 k €↑
  9. 2017
    Annual accounts 2017-131,8 k €↑
  10. 2017
    Name changeEurotranspharma Belgium
  11. 2016
    Annual accounts 2016-368,4 k €↑
  12. 2015
    Annual accounts 2015-391,1 k €↑
  13. 2014
    Annual accounts 2014-512,5 k €
  14. 2014
    Name changeTranspharma Belgium
  15. 04/11/2013
    IncorporationPrivate limited company